The consistent direction of the Lactobacillus association, despite borderline significance, reinforces the plausibility of microbiota involvement in SGLT2i benefits.
← all excerpts
Long-term efficacy of dapagliflozin combined with Bifidobacterium triple viable tablets on metabolic syndrome and gut microbiota in overweight/obese patients with type 2 diabetes.
1
—
—